Imiglucerase

Imiglucerase is a medication used to treat Gaucher disease, a genetic disorder where a harmful fatty substance builds up in certain organs due to missing or defective enzymes. It is a form of enzyme replacement therapy, meaning it provides the body with the enzyme it lacks, helping to reduce this buildup. Imiglucerase is produced using biotechnology, specifically made in labs through cell cultures. By restoring enzyme activity, it helps alleviate symptoms like enlarged liver or spleen, bone problems, and blood issues, improving patients’ overall health and quality of life.